The study taps into the sophisticated immune mechanisms elicited by the widely administered MMR vaccine, which has controlled measles incidence for decades. Despite vaccination efforts, recent declines in vaccine coverage have precipitated dangerous outbreaks, highlighting an urgent need for alternative prophylactic and therapeutic strategies. This is particularly critical for immunocompromised individuals—such as pregnant women, chemotherapy patients, and infants under one year old—who are ineligible to receive live attenuated vaccines due to safety concerns.

Leveraging advanced structural biology techniques, including cryo-electron microscopy (cryo-EM), the researchers unlocked detailed three-dimensional images of how naturally occurring human antibodies target two key viral components: the hemagglutinin (H) attachment protein and the fusion (F) surface protein. These proteins play pivotal roles in mediating viral entry and membrane fusion, processes integral to establishing infection. The antibodies were isolated from a human donor previously vaccinated against measles, providing real-world insight into the immune response generated by the vaccine.

Remarkably, the antibodies showed extraordinary potency, exhibiting binding affinities two orders of magnitude greater than previously characterized monoclonal antibodies. This superior efficacy was noted across different antibody specificities, targeting both the viral fusion apparatus and its receptor-binding interface. Mechanistically, the antibodies directed at the F protein exert their neutralizing effect by locking the fusion machinery into an inactive conformation, thereby thwarting the virus’s ability to undergo the structural rearrangements necessary for host cell membrane fusion and entry.

Preclinical evaluations conducted in collaboration with The Ohio State University utilized cotton rat models, a standard for studying respiratory viral infections. These experiments demonstrated that administration of the antibody panel significantly reduced the measles viral load when delivered either prophylactically before viral exposure or therapeutically within 24 to 48 hours post-infection. Intriguingly, one antibody, designated 3A12, completely eliminated detectable circulating virus in the bloodstream, underscoring its potential as a transformative therapeutic agent.

The promise of monoclonal antibody therapies lies in their specificity and replicability. These therapies provide a concentrated dose of targeted immune molecules capable of neutralizing pathogens directly. The success of antibody-based interventions against respiratory syncytial virus (RSV) sets a precedent, and the current findings suggest measles could be the next frontier for such precision immunotherapies. Effectively, these antibodies could serve as both a first line of defense in vaccine-ineligible individuals and as a treatment to mitigate disease progression in those already infected.

This discovery is particularly poignant in the context of waning herd immunity. The protective barrier afforded by community vaccination rates has diminished, increasing the risk of measles outbreaks that jeopardize public health, especially among susceptible populations. Therein lies the critical utility of antibody therapies: they can fill the gap for those who are unable or yet to be vaccinated, providing immediate and robust protection during outbreaks.

From a molecular standpoint, the research elucidates the dynamic interplay between viral surface glycoproteins and the host immune response. The structural snapshots afforded by cryo-EM reveal how antibodies incapacitate viral machinery, preventing the conformational shifts required for fusion and entry. This granular understanding is invaluable for rational design of antibody-based therapeutics and may inform future vaccine enhancements as well.

The study was meticulously conducted, with a multidisciplinary team of immunologists, structural biologists, and virologists contributing to the comprehensive analysis. The collaboration exemplifies the power of combining structural insights with in vivo efficacy data. The strategic use of a clinical volunteer’s blood sample allowed for isolation of naturally elicited human antibodies, ensuring clinical relevance and optimizing the potential for translation into human treatments.

Looking ahead, ongoing research efforts are focused on scaling production of these antibodies and conducting further preclinical safety and efficacy testing. The pathway is now clearer toward developing the first-ever before- or after-exposure treatment for measles, a goal that could revolutionize management of this ancient yet persistently challenging viral disease. As researchers refine these candidates, the anticipation builds for clinical trials that may validate their therapeutic potential.

In a statement reflecting on the significance of the discovery, LJI President and CEO Erica Ollmann Saphire, Ph.D., emphasized that these antibodies “may offer a way to deliver the immune response that people wish they had” — providing both protection and treatment where vaccination is not an option. This represents a profound step forward in the armamentarium against measles, moving beyond prevention to actionable therapy.

Ultimately, the convergence of cutting-edge structural biology, immunology, and translational research exemplified by this study heralds a new era in measles management. With scientific momentum building, antibody-based interventions promise to safeguard the most vulnerable and curtail the spread of a virus once thought nearly eradicated. This research not only advances measles therapeutics but also underscores the broader potential of monoclonal antibodies in combating infectious diseases worldwide.

Subject of Research: Animals

Article Title: Human neutralizing antibodies targeting the Measles virus hemagglutinin and fusion surface proteins

News Publication Date: 7-May-2026

Web References: http://dx.doi.org/10.1016/j.chom.2026.04.010

Image Credits: Dawid Zyla, La Jolla Institute for Immunology

Keywords: Viral infections, Preventive medicine, Vaccine research, Vaccine target, Microbiology, Viral entry, Viral pathogenesis, Viruses, Virology, Microscopy, Immunology, Monoclonal antibodies, Neutralizing antibodies, Antibody therapy

HSV-1 is an enveloped virus responsible for a range of diseases, from oral cold sores to potentially life-threatening encephalitis, affecting millions globally. Central to the virus’s ability to infect host cells is gB, a highly conserved viral fusion protein that orchestrates the merger of the viral envelope with host cell membranes, a prerequisite for viral entry. Despite its critical role, the prefusion conformation of gB has long evaded structural characterization, limiting scientists’ capacity to fully understand its function and immune interaction dynamics.

In this seminal investigation, the research team employed advanced cryo-electron microscopy (cryo-EM) techniques to capture and reconstruct the elusive prefusion state of HSV-1 gB at near-atomic resolution. This approach enabled them to visualize the spatial arrangement of gB’s domains sharply before the protein undergoes the dramatic conformational changes necessary for membrane fusion. Previous studies had predominantly characterized postfusion structures, which represent the protein after its functional role in membrane merger, thus missing the critical initial conformational landscape.

Detailed structural analysis revealed that gB adopts a highly metastable configuration in its prefusion form, stabilized by a complex network of intramolecular interactions. Notably, the fusion loops, known for inserting into host membranes during the fusion process, are sequestered in a way that prevents premature exposure, underscoring a finely tuned mechanism of activation. This conformation likely represents a vulnerable window during which neutralizing antibodies can bind and block the fusion event, a potential Achilles’ heel for the virus.

Accompanying their structural insights, the researchers also explored how HSV-1 gB subverts the host immune response. Glycoprotein B is known to be a major target for neutralizing antibodies, yet HSV-1 deftly evades neutralization, allowing persistent infections and periodic reactivation. The study uncovered that gB’s prefusion form exhibits glycan shields and conformational masking that obscure critical epitopes from immune surveillance. This strategic cloaking likely limits the efficacy of antibody binding during natural infection and highlights the challenges in eliciting protective immunity via traditional vaccine approaches.

In addition to structural characterization, the study dissected the binding properties of several potent neutralizing antibodies isolated from infected individuals. These antibodies were found to preferentially recognize and stabilize the prefusion conformation of gB, effectively locking it in a non-functional state and preventing membrane fusion. Such detailed understanding of antibody binding modes provides valuable clues for the design of immunogens capable of eliciting similarly protective responses.

Crucially, the findings have broad implications for antiviral drug development. By defining the molecular landscape of prefusion gB, the team has identified potential small-molecule binding pockets and allosteric sites that could be exploited to design fusion inhibitors. These novel antiviral agents would act by stabilizing gB in its prefusion state or by disrupting the finely balanced conformational shifts necessary for fusion, cutting off the virus at its point of entry.

From a vaccine perspective, the study lays the foundation for next-generation HSV-1 vaccines that focus on presenting the prefusion form of gB as an immunogen. Traditional HSV vaccines have struggled partly due to the dynamic nature of gB and the predominance of postfusion epitopes, which are less effective in eliciting neutralizing antibodies. Stabilizing and displaying the prefusion gB trimer could focus immune responses on functionally relevant and vulnerable sites, enhancing vaccine efficacy and durability.

Moreover, this research sheds light on the evolutionary arms race between HSV-1 and the human immune system. The elegant structural mechanisms of immune evasion documented here reflect sophisticated viral adaptation, highlighting the challenges of mounting an effective immune defense against herpesviruses. Understanding these sophisticated escape strategies also informs broader virology, as similar principles may apply to other class III fusion proteins found across diverse viral families.

The methodology used in this study is a striking example of how integrated structural biology techniques, including cryo-EM, X-ray crystallography, and computational modeling, can be leveraged to tackle previously intractable viral proteins. By synergistically combining these approaches, the authors provided not only static structural data but also dynamic insights into the conformational flexibility and activation pathways of gB, enriching the functional narrative.

Equally important, the study establishes a framework to investigate glycoprotein B homologs in related herpesviruses, such as HSV-2, varicella-zoster virus, and cytomegalovirus. Given the conserved nature of this fusion machinery, the insights gained here could accelerate cross-species antiviral strategies and foster a unified approach to combat herpesvirus infections more broadly.

The intricate dance between viral glycoproteins and host cell membranes is fundamental to viral infectivity, and this study advances our grasp on one of nature’s most complex fusion machineries. By elucidating the prefusion structure and immune evasion tactics of HSV-1 gB, this work marks a transformative leap toward therapeutic innovations that could significantly reduce the global burden of herpes simplex virus infections.

In conclusion, this landmark investigation by Roark, Schaub, Shi, and colleagues propels our understanding of HSV-1 biology into an unprecedented molecular realm. By revealing the architecture of gB before membrane fusion, decoding the immune evasion landscape, and mapping neutralization vulnerabilities, they unlock a new frontier in herpesvirus research. The translational potential of these findings for antiviral drugs and vaccines promises to energize the field and offers hope for more effective interventions against this pervasive pathogen.

Subject of Research: Structural characterization, immune evasion, and neutralization mechanisms of herpes simplex virus 1 glycoprotein B (HSV-1 gB).

Article Title: Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B.

Article References:
Roark, R.S., Schaub, A.J., Shi, W. et al. Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02153-x

Image Credits: AI Generated

HIV-1 remains a global health crisis, with approximately 40 million people living with the virus worldwide. Despite progress in managing the disease through antiretroviral therapy, challenges such as drug resistance, side effects, and social stigma persist, underscoring the urgent need for new therapeutic strategies. Integrase, long recognized for its function in inserting viral DNA into the infected host’s genome, has now been found to also engage viral RNA at later stages—highlighting previously uncharacterized roles in the HIV lifecycle.

The Salk research team employed cryo-electron microscopy (cryo-EM) to capture integrase in two distinct structural conformations. Initially, integrase operates as part of a massive “intasome” complex, consisting of four identical subunits arranged into a 16-part assembly. This architecture tightly encircles viral DNA, orchestrating its integration into the host genome, a critical step that establishes permanent infection within the host cell.

Later in the replication process, integrase adopts a drastically different form. It transitions from the large intasome to a minimalist four-part complex, a configuration associated with binding to viral RNA inside the HIV capsid. This structural transition from DNA-focused activity to RNA interaction reveals the protein’s adaptability and suggests additional layers of complexity in HIV’s replication machinery.

This discovery marks the first time researchers have visualized integrase’s RNA-bound state, providing a high-resolution blueprint for this elusive form. Such structural insights are invaluable, as the design of targeted inhibitors typically relies on detailed knowledge of a protein’s 3D configuration to effectively disrupt its function without off-target effects.

The implication of integrase functioning beyond DNA integration is profound. While current integrase inhibitors such as Dolutegravir effectively block the protein’s DNA integration role, HIV’s rapid mutation rate often leads to resistance. By targeting integrase’s secondary role in RNA interaction, drug developers may circumvent existing resistance mechanisms, opening the door to new classes of antiretroviral therapies.

Senior author Dmitry Lyumkis, PhD, emphasizes the significance of these findings: “We are only beginning to understand the multifunctionality of integrase proteins. Mapping its interaction with RNA not only enriches our knowledge of viral biology but also informs the rational design of next-generation HIV therapeutics.”

At the molecular level, HIV’s retroviral replication strategy involves reverse-transcribing its RNA genome into DNA, which is then inserted into the host’s genome via integrase. This insertion transforms the host cell into a viral factory, producing progeny RNA that is packaged for new infections. Understanding the full scope of integrase’s roles in this cycle is essential for developing comprehensive antiviral strategies.

The integrase’s structural plasticity uncovered by the Salk team illustrates the dynamic nature of viral proteins. Their data show how subtle shifts in quaternary structure—disassembling from a 16-subunit “lock” to a compact 4-subunit complex—enable integrase to pivot between its DNA and RNA binding functions. Such dynamic assembly-disassembly processes could be exploited pharmacologically to trap the protein in inactive states.

This research represents a collaboration among numerous experts across molecular biology, structural biology, and virology, including significant contributions from partnering institutions such as the University of Colorado School of Medicine, Dana-Farber Cancer Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases. Their collective expertise underscores the complexity and interdisciplinary nature of combatting HIV.

The study also showcases the power of cryo-electron microscopy, which has revolutionized structural biology by enabling the visualization of large and flexible protein complexes in near-native states. The high-resolution cryo-EM maps generated by the researchers provide unparalleled detail into integrase’s architecture, setting a new standard for future investigations of viral proteins.

Beyond its scientific merit, this discovery carries translational potential for public health. Novel integrase inhibitors targeting both DNA and RNA-related functions may reduce drug resistance, improve treatment durability, and mitigate adverse effects. Such advances are critical in the ongoing global effort to curb HIV transmission and improve the quality of life for millions affected by the virus.

As the scientific community digests these findings, follow-up studies are anticipated to confirm integrase’s RNA interaction mechanisms, assess their roles in viral encapsidation and infectivity, and explore the potential for targeting these interactions therapeutically. This evolving picture of integrase’s biology promises to reshape HIV drug development paradigms in the coming years.

The Salk Institute’s pioneering research not only deepens our fundamental understanding of HIV biology but also exemplifies the fusion of structural insights and therapeutic innovation. With new blueprints in hand, drug designers are now better equipped than ever to develop integrase-targeting agents that could transform the clinical management of HIV-1 infection and ultimately help turn the tide against this enduring pandemic.

Subject of Research: Structural and functional analysis of HIV-1 integrase in its dual roles interacting with viral DNA and RNA.

Article Title: Structural Elucidation of HIV-1 Integrase Reveals Dual Functionality in Viral DNA Integration and RNA Interaction

News Publication Date: October 24, 2025

Web References:
https://www.nature.com/articles/s41467-025-64479-8

References:
Lyumkis, D., Jing, T., Shan, Z., et al. (2025). Structural insights into HIV-1 integrase functions during DNA integration and RNA interaction. Nature Communications. DOI: 10.1038/s41467-025-64479-8

Image Credits:
Salk Institute

The study focused on the L-P complex of Nipah virus, wherein the large L protein, a multifunctional RNA-dependent RNA polymerase (RdRp), associates tightly with the phosphoprotein (P) cofactor. Employing advanced cryo-EM techniques, the investigators resolved two apo-state structures of this complex, capturing snapshots of the viral polymerase machinery with unprecedented clarity. The L protein was found to exhibit distinct RdRp and PRNTase (polyribonucleotidyltransferase) domains, crucial for nucleotide polymerization and RNA capping, respectively. The flexibility of the C-terminal domains, including the connector domain (CD), methyltransferase (MTase), and C-terminal domain (CTD), was notable, manifesting as unresolved regions in the cryo-EM maps, emphasizing their dynamic nature during the viral RNA synthesis cycle.

Integral to the polymerase function is the P protein tetramer, which mediates crucial interactions with the L protein. Structural observations revealed that the P protein tetramer anchors firmly to the RdRp domain of L through a series of complex interfaces. Notably, the XD domain of one P protomer (P1) was positioned strategically above the nucleotide triphosphate (NTP) entry channel, with its linker region draped across this pathway. This specific orientation suggests a regulatory mechanism whereby the P protein modulates access to the RNA template and nucleotide substrates, ensuring controlled and efficient RNA elongation. Other subunits of the tetramer, specifically P3 and P4, employed hydrophobic interactions, hydrogen bonding, and cation-π engagements to secure their positions on the L protein surface, highlighting a finely tuned protein-protein interaction network fundamental to polymerase stability and function.

A hallmark discovery of this work was the identification of two evolutionarily conserved zinc-binding motifs within the PRNTase domain of the L protein. These motifs, coordinated by conserved cysteine and histidine residues, form distinct zinc finger-like structures vital for enzymatic activity. Functional assays employing alanine substitution mutagenesis at these zinc-coordinating residues demonstrated a complete abrogation of polymerase activity, unequivocally establishing their catalytic indispensability. The conservation of these zinc-binding sites across mononegaviruses, with the notable exception of pneumoviruses, points to a shared mechanistic theme among diverse viral families and underscores their potential as broad-spectrum antiviral targets.

Mutagenesis experiments further extended to disrupt the L-P interfaces, particularly focusing on regions mediating the anchorage of the P protein tetramer to the L polymerase. These perturbations resulted in a marked decrease in polymerase enzymatic functionality and compromised the structural stability of the L protein itself. Such findings illuminate the intricate interdependence of L and P proteins within the replication complex, emphasizing that precise protein interactions are not merely structural but also critical for catalytic competence.

Comparative structural analyses with polymerase complexes from other Mononegavirales viruses, including Newcastle disease virus (NDV) and Ebola virus (EBOV), revealed both conserved and divergent elements in P protein binding dynamics. A conserved tyrosine residue on the L surface was identified as a pivotal anchoring point for P tetramers across species, exemplified by Y732 in NiV, Y651 in NDV, and Y642 in EBOV. Despite this conservation, the positioning and flexibility of the P protein’s C-terminal domains varied significantly, suggesting adaptation of polymerase architecture tailored to viral-specific replication strategies.

The flexibility observed in the unresolved C-terminal regions of the L protein may reflect conformational plasticity necessary for multifunctional enzymatic activities, including mRNA capping and methylation. Such dynamics could facilitate temporal regulation of RNA synthesis and processing, ensuring the production of viral transcripts with proper modifications required for efficient translation and immune evasion.

This comprehensive structural and functional characterization of the Nipah virus polymerase complex not only advances fundamental virology but provides a robust framework for rational inhibitor design. Targeting the conserved zinc-binding motifs or disrupting key L-P interactions offers promising approaches for antiviral development. Moreover, the unique structural features identified, such as the P protein’s XD linker occluding the nucleotide entry channel, may be exploited to design allosteric inhibitors that impair polymerase function without directly competing with nucleotide substrates.

Given the high fatality rates and epidemic potential associated with Nipah virus outbreaks, this study’s insights are particularly timely. They contribute to the growing arsenal of molecular data critical for preemptive antiviral discovery against paramyxoviruses and related pathogens. By delineating the virus’s replication machinery at near-atomic resolution, researchers establish a foundation upon which future therapeutic interventions can be built, potentially mitigating the devastating impact of zoonotic viral epidemics worldwide.

The methodologies deployed in this research included direct visualization via cryo-EM of purified L-P complexes, complemented by site-directed mutagenesis and mini-replicon assays to validate functional consequences of perturbations. This integrative approach exemplifies the power of combining structural biology with molecular virology to dissect complex viral enzymatic systems.

Ultimately, the elucidation of the NiV polymerase architecture enriches our comprehension of viral RNA synthesis and identifies mechanistic nuances that distinguish paramyxoviruses from other mononegaviruses. This knowledge paves the way for the development of broad-spectrum antivirals that target deeply conserved viral components, representing a crucial step forward in combating emergent viral threats and safeguarding global health.

Subject of Research: Not applicable

Article Title: Cryo-EM structures of Nipah virus polymerase complex reveal highly varied interactions between L and P proteins among paramyxoviruses

News Publication Date: 18-Feb-2025

Web References: http://dx.doi.org/10.1093/procel/pwaf014

References: [Xue L, Chang T, Gui J, Li Z, Zhao H, Zou B, Lu J, Li M, Wen X, Gao S, Zhan P, Rong L, Feng L, Gong P, He J, Chen X, Xiong X. Cryo-EM structures of Nipah virus polymerase complex reveal highly varied interactions between L and P proteins among paramyxoviruses. Protein & Cell. 2025 Feb 18.]

Image Credits: Xue L, Chang T, Gui J, Li Z, Zhao H, Zou B, Lu J, Li M, Wen X, Gao S, Zhan P, Rong L, Feng L, Gong P, He J, Chen X, Xiong X

Keywords: Cells

At the heart of arenavirus infectivity lies the spike glycoprotein complex embedded within the viral envelope. This complex orchestrates the initial attachment and subsequent fusion of the virus with host cell membranes—an essential step for viral genome delivery and infection. Unlike many other viral spike proteins that have been extensively studied, the arenavirus glycoprotein complex exhibits a distinctive organization and processing pathway that has until now remained incompletely understood. The recent study utilizes state-of-the-art cryo-electron microscopy (cryo-EM) combined with advanced biochemical techniques to resolve the high-resolution structure of this trimeric complex in its prefusion conformation.

The study reveals that the arenavirus spike complex constitutes three non-covalently linked subunits arranged symmetrically around a central axis. This trimeric architecture exhibits a sophisticated molecular choreography that balances structural stability with conformational flexibility, enabling the transition from receptor binding to membrane fusion. Intriguingly, the glycoprotein complex consists of a stable receptor-binding domain that interfaces with host cell receptors and a metastable fusion machinery poised to undergo dramatic conformational rearrangements upon activation. This interplay ensures that membrane fusion is tightly regulated and occurs only under appropriate cellular conditions.

One of the most fascinating discoveries pertains to the unique cleavage and maturation process of the glycoprotein precursor, which is cleaved into a tripartite complex comprised of the receptor-binding subunit, the transmembrane fusion subunit, and a stable signal peptide that remains associated within the complex. This tripartite assembly departs from canonical viral glycoprotein processing pathways and contributes both to structural integrity and functional regulation. The stable signal peptide, in particular, acts as an intramolecular chaperone and an essential component of the spike complex, a feature that may be exploited for therapeutic intervention.

The structural study details the glycosylation landscape surface of the complex, highlighting how the sugar moieties create a protective shield that impedes neutralizing antibodies. Glycosylation patterns on viral spikes often represent a double-edged sword: they can facilitate immune escape yet potentially present vulnerabilities that immune targeting strategies can exploit. Observed glycan clusters appear to selectively mask vulnerable epitopes without compromising receptor engagement, underscoring the evolutionary fine-tuning of arenaviruses to circumvent host immunity while maintaining infectivity.

Beyond mere structure, the functional implications of the glycoprotein architecture were interrogated through mutational analyses and receptor binding assays. These experiments confirmed that the proper assembly and spatial arrangement of the subunits are critical for viral entry. Mutations disrupting intersubunit interfaces or glycan placements markedly diminished virus-cell fusion efficiency, emphasizing that both structural conformation and post-translational modifications collectively dictate viral fitness. Such mechanistic insights provide essential blueprints to disrupt key viral processes pharmacologically.

Comparative analysis with Old World arenaviruses and other enveloped viruses reveal both conserved and distinctive features. While the general paradigm of trimeric spike assembly and fusion activation is evolutionarily conserved, the New World arenavirus spike complex exploits a notably divergent receptor engagement strategy. This divergence likely mirrors adaptation to distinct receptor repertoires on host cell surfaces and facilitates tissue tropism differences. Hence, therapeutic designs need to be tailored specifically to these structural nuances to achieve broad-spectrum efficacy.

Moreover, the study sheds light on the dynamics of the prefusion-to-postfusion conformational changes, which are energetically demanding yet critical for viral membrane merger. The prefusion spike exists in a metastable state stabilized by strategic molecular contacts, which, upon triggering by receptor interaction and cellular cues such as low pH, rapidly transitions into an extended postfusion state that drives membrane apposition and fusion pore formation. These snapshots captured by cryo-EM not only depict the static architecture but also illuminate the underlying molecular mechanics of viral entry.

The implications of this work extend into vaccine research. Understanding the precise molecular arrangement of the spike glycoprotein allows the rational design of immunogens that mimic the native prefusion conformation, thereby eliciting neutralizing antibody responses more effectively. Stabilizing the spike in its prefusion state might improve the antigenic fidelity of vaccine candidates, a strategy successfully employed against respiratory syncytial virus and coronaviruses. Given the lack of licensed vaccines for many New World arenaviruses, this structural blueprint represents a critical step toward immunoprophylactic solutions.

From a therapeutic standpoint, small molecule inhibitors or monoclonal antibodies targeting the glycoprotein interfaces, glycan shields, or fusion machinery could prove invaluable. The identified allosteric sites and conserved residues essential for conformational changes offer promising targets for drug development. The study forces a reevaluation of arenavirus vulnerability landscapes and encourages investment in targeted antiviral discovery pipelines that exploit these newly mapped molecular architectures.

Furthermore, the research opens avenues to explore how viral evolution shapes glycoprotein structure in response to immune pressure and interspecies transmission barriers. Structural plasticity and glycan remodeling may underpin the zoonotic potential of arenaviruses and their ability to evade pre-existing immunity. Continuous surveillance of glycoprotein sequence variation coupled with structure-function analyses will be essential to anticipate emerging strains and guide public health responses.

In conclusion, the comprehensive molecular elucidation of the New World arenavirus glycoprotein spike presents a cornerstone advancement in our understanding of arenavirus biology. These complex viral machineries, finely tuned through evolution, blend structural ingenuity with functional precision to facilitate infection in hostile host environments. The amalgamation of cutting-edge structural biology with virological experimentation showcased in this study not only fills a critical knowledge gap but also lays a robust framework for translational efforts aiming to mitigate arenavirus-related diseases.

As arenaviruses continue to pose a significant threat to global health, particularly in Latin America where outbreaks remain a persistent concern, advances such as these are invaluable. They provide the detailed molecular targets necessary to steer the next generation of vaccine and antiviral strategies. Moreover, this study exemplifies how multidisciplinary approaches integrating structural and molecular virology yield insights with tangible real-world impacts against emerging viral pathogens.

Looking ahead, future studies may focus on the dynamics of glycoprotein interactions with host receptor variants, immune evasion tactics mediated by glycan variants, and integration of these molecular insights within cellular and animal models of pathogenesis. Continuous efforts to map structural changes under physiological conditions will further enhance the relevance of these findings.

Ultimately, this breakthrough underscores the power of modern structural biology to unravel the complex molecular machines viruses employ. As global health is continually challenged by viral emergence, such detailed molecular portraits remain our most potent tools to design effective countermeasures and safeguard human populations worldwide.

Subject of Research: Molecular architecture and functional organization of the New World arenavirus spike glycoprotein complex.

Article Title: Molecular organization of the New World arenavirus spike glycoprotein complex.

Article References:
Mann, C.J., Yang, P., Olal, D. et al. Molecular organization of the New World arenavirus spike glycoprotein complex. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02085-6

Image Credits: AI Generated

The typical paradigm in herpesvirus biology posits that glycoproteins H (gH) and L (gL) function together as a core fusion machinery partnering with other viral proteins to mediate virus-host cell membrane fusion and entry. HCMV, as with other herpesviruses, assembles distinct gH/gL-based complexes with various accessory proteins to achieve cell-type-specific entry, a feature that complicates the landscape of viral tropism. Historically, two well-characterized complexes – the trimeric gH/gL/gO and the pentameric gH/gL/UL128-UL130-UL131A – have defined tropism for fibroblasts and epithelial/endothelial cells respectively. However, these canonical complexes do not fully account for all modes of endothelial infection, suggesting the existence of alternative entities.

In their pivotal study, Norris and colleagues have unveiled a third virion surface complex composed of gH associating not with gL, but with two distinct viral proteins, UL116 and UL141. Intriguingly, UL141 had been primarily recognized as an intracellular immunoevasin, interacting with host cell immune receptors to subvert immune detection. Its extracellular presence on the virion surface in conjunction with gH and UL116, however, expands its functional repertoire dramatically. This new complex, dubbed the GATE (gH-associated tropism and entry) complex, challenges the canonical dogma that gH must be complexed with gL to mediate entry, revealing a novel paradigm in HCMV biology.

The detailed structural analysis, achieved through high-resolution cryo-electron microscopy at approximately 3.5 Å resolution, offers unprecedented insights into the molecular architecture of the GATE complex. The structure revealed that gH forms a scaffold independently of gL, an unusual feature within the Herpesviridae glycoprotein family. UL141 mediates dimerization, effectively crosslinking two gH molecules, while UL116 forms a heavily glycosylated cap that adorns the complex’s distal end. This heavy glycosylation likely contributes to immune evasion by shielding key epitopes from host immune recognition, a strategy commonly employed by viruses to persist in the host.

The functional consequences of this complex are striking. The GATE complex significantly enhances viral entry specifically into endothelial cells, which are critical conduits for viral circulation and likely facilitate dissemination of HCMV throughout the host. Given endothelial involvement in vascular inflammation and barrier integrity, the presence of GATE could underlie some of the vascular pathologies observed during congenital infection and in immunocompromised patients. The identification of this novel entry complex thus not only fills a critical knowledge gap but also provides a potential Achilles’ heel for future therapeutic intervention.

Molecularly, the absence of gL in the complex is particularly significant. gL has been considered indispensable for stabilizing gH and facilitating its maturation and trafficking in other herpesviruses. That HCMV can repurpose gH into a stable, functionally active complex without gL indicates a remarkable plasticity in this virus’s entry machinery. UL116 appears to compensate for the absence of gL, potentially by stabilizing the gH conformation and facilitating interactions with UL141. This modularity might confer the virus flexibility to infect a wider range of cell types or evade neutralization by antibodies targeting canonical gH/gL epitopes.

The role of UL141 as a dimerizing agent within the complex is also mechanistically captivating. Past studies focusing on its immunoevasin role positioned UL141 as an intracellular modulator of host immune functions, notably by downregulating ligands critical for natural killer (NK) cell recognition. Its virion surface function introduces the possibility that UL141 acts as a dual-purpose protein, contributing both to immune evasion and facilitating viral entry. This duality could represent an evolutionary advantage, allowing the virus to coordinate cell entry with simultaneous modulation of host immune responses.

From a vaccine and antiviral therapeutic standpoint, targeting the GATE complex presents a novel opportunity. Traditional vaccine candidates have primarily focused on the trimeric and pentameric gH/gL complexes, given their known involvement in viral entry. The discovery of GATE suggests that additional antigens may need to be incorporated to elicit broadly effective neutralizing antibody responses. Moreover, the unique structural features and glycosylation patterns of the GATE complex could be exploited to design inhibitors that block endothelial infection selectively, potentially curtailing the virus’s systemic spread.

Beyond structural and functional insights, this finding raises important questions about viral evolution and tropism adaptation. How did HCMV evolve this alternative gH complex, and what pressures selected for its emergence? Does the GATE complex contribute to infection in other cell types or physiological contexts? Future studies are needed to dissect the biological significance of this complex in vivo and assess its prevalence across clinical isolates and strains, considering HCMV’s notorious genetic diversity.

The discovery of the GATE complex also prompts a reexamination of prior models of HCMV entry. It challenges the field to revisit assumptions about the exclusivity of gH/gL complexes and the modularity of viral entry machinery. Since gH/gL complexes have served as prototypical drug and vaccine targets, the recognition that gH can partner with alternative proteins necessitates broader strategies that account for this variability. This shifts the paradigm from a linear, rigid model to a more dynamic and adaptable framework of herpesvirus entry.

Technologically, the application of cryo-electron microscopy at near-atomic resolution was instrumental in this discovery. The visualization of the stoichiometry, glycosylation sites, and interaction interfaces between gH, UL116, and UL141 evidences the power of modern structural biology techniques to reveal complex viral architectures that were previously inaccessible. Such detailed structural knowledge not only advances fundamental virology but also informs rational drug design and vaccine engineering.

Furthermore, the heavily glycosylated UL116 “cap” on the GATE complex surfaces provides an elegant example of viral camouflage. Glycans are often exploited by viruses as a “shield” to evade antibody neutralization while retaining receptor binding functionality. Decoding the glycosylation patterns on UL116 may uncover vulnerabilities; for example, conserved glycan structures could serve as epitopes for broadly neutralizing antibodies or lectin-based inhibitors.

This study also underscores the interplay between viral entry proteins and immune evasion factors. UL141, previously viewed as an immunomodulatory protein operating within infected cells, emerges here as a structural component directly facilitating entry. This multifunctionality exemplifies viral economy and evolutionary finesse, wherein a single protein can fulfill diverse roles to optimize infectivity and persistence.

In sum, the elucidation of the GATE glycoprotein complex constitutes a landmark advance in understanding human cytomegalovirus biology. It opens a new frontier for research into herpesvirus entry mechanisms and pathogenesis, expanding the arsenal of potential targets for vaccines and antivirals. As HCMV remains a leading cause of birth defects and morbidity in immunocompromised hosts worldwide, such discoveries are critical milestones toward mitigating this pervasive pathogen’s impact.

Looking forward, integration of these structural findings with functional virology, immunology, and clinical studies will be vital. Dissecting how the GATE complex interacts with host endothelial receptors, the immunological consequences of its expression, and variations among viral strains will shape next-generation therapeutic strategies. The identification of GATE calls for a reevaluation of canonical herpesvirus entry frameworks and underscores the complexity embedded within viral entry—a process that is finely tuned to exploit host cell biology for successful infection.

As researchers continue to unravel the sophisticated strategies deployed by HCMV, the discovery of the GATE complex highlights the importance of investigating viral protein interactions beyond known paradigms. It reminds us that viruses are masterful engineers of molecular innovation, capable of surprising us with new mechanisms that challenge existing dogmas and open novel routes to intervention.

Subject of Research: Human cytomegalovirus glycoprotein complexes mediating viral entry into endothelial cells

Article Title: The GATE glycoprotein complex enhances human cytomegalovirus entry in endothelial cells

Article References:
Norris, M.J., Henderson, L.A., Siddiquey, M.N.A. et al. The GATE glycoprotein complex enhances human cytomegalovirus entry in endothelial cells. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02025-4

Image Credits: AI Generated

Bacteriophages, or phages, are viruses that infect and invade bacterial cells, leveraging their host machinery to replicate. The infection process commences with the phage’s surface adhesins attaching to specific bacterial receptors, a crucial step determining host range and infection efficacy. The family Straboviridae, encompassing a diverse group of lytic phages, has been enigmatic in terms of the exact molecular interactions governing their attachment to Gram-negative bacteria. The current research addresses this gap by focusing on Gp38 adhesins, key viral proteins implicated in receptor binding.

Utilizing advanced cryo-electron microscopy (cryo-EM) combined with mutational mapping of bacterial receptor proteins, the study reveals that Gp38 adhesins engage in highly specific interactions with extracellular loops on outer membrane proteins (OMPs) of target bacteria. These loops protrude from the bacterial surface, serving as accessible binding sites. The fidelity of this binding determines phage infectivity, dictating which bacterial strains are vulnerable to particular Straboviridae phages. Notably, the binding involves a precise complementarity between the phage adhesin structure and the spatial conformation of the target loops.

The team employed recombinant expression systems to produce isolated Gp38 protein variants and synthetic bacterial OMP loop peptides. Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) quantified the binding affinities, confirming the critical role of certain amino acid residues within the loops for high-affinity interactions. Mutagenesis experiments, where these residues were systematically altered, demonstrated a significant decrease or complete loss of phage adsorption, providing functional validation of the binding determinants.

Beyond structural insights, the research elucidates evolutionary aspects of phage-host interaction. Sequence comparisons across diverse Straboviridae Gp38 proteins reveal conserved motifs responsible for loop recognition, interspersed with variable regions likely enabling adaptation to different bacterial receptors. This balance of conservation and variability underpins the evolutionary arms race, whereby bacteria often modify surface loops to evade phage predation, while phages adapt their adhesins to regain infectivity.

The implications of these findings transcend basic virology. With the resurgence of antibiotic-resistant bacterial infections, phage therapy has reemerged as a promising alternative. Understanding the molecular basis of phage-host specificity is vital for engineering phages with targeted antibacterial activity. The detailed map of Gp38-OMP interactions provides a blueprint for designing synthetic adhesins or modifying natural ones to retarget phages against pathogenic bacteria expressing altered or novel surface proteins.

Moreover, the study indicates potential for using Gp38 adhesins as diagnostic tools. Because these proteins recognize unique extracellular loop conformations, they could be harnessed as molecular probes to detect specific bacterial strains in clinical or environmental settings. This specificity could improve bacterial typing and facilitate rapid identification of infectious agents, enhancing personalized treatment strategies.

Crucially, the research highlights the dynamic nature of outer membrane proteins in bacterial physiology. The loops targeted by phages often play roles in nutrient uptake, structural integrity, or immune evasion. Phage binding could, therefore, influence bacterial function beyond mere infection, possibly modulating bacterial behavior or fitness. Understanding these nuanced interactions might reveal new layers of complexity in microbial ecosystems and host-pathogen dynamics.

The methods applied in this study exemplify the power of interdisciplinary approaches. Integrating structural biology, microbiology, biophysics, and evolutionary bioinformatics enabled a comprehensive characterization of Gp38 adhesins. This multifaceted strategy facilitates not only the identification of binding sites but also the understanding of their functional and evolutionary context, underscoring the increasing sophistication in phage research methodologies.

Looking forward, the team envisions expanding their work to explore Gp38 interactions with a broader repertoire of bacterial receptors. Such studies would unravel the versatility and plasticity of phage adhesins, illuminating how these viruses navigate the complex topography of bacterial surfaces. Furthermore, in vivo investigations may elucidate how these molecular mechanisms translate into infection dynamics within natural bacterial communities or clinical infections.

The study also raises intriguing questions about the co-evolutionary pressures shaping bacterial membrane proteins. Since phage recognition depends on accessible extracellular loops, bacteria face trade-offs between mutating these loops to evade infection and preserving essential functions. This evolutionary tension likely drives diversity in both bacterial surface proteins and phage adhesins, contributing to the rich molecular interplay observed in microbial ecosystems.

Additional research inspired by these findings might focus on engineering synthetic phages equipped with designer Gp38 adhesins, tailored for targeted bacterial eradication. Such synthetic biology approaches could revolutionize antimicrobial strategies, offering precise and adaptable tools against resistant pathogens. The molecular resolution provided by this study lays the groundwork for these transformative applications.

In summary, the elucidation of Gp38 adhesin recognition of specific extracellular loops in bacterial OMPs represents a substantial advancement in viral attachment biology. This work not only deciphers the molecular underpinnings of Straboviridae phage specificity but also catalyzes future research spanning evolutionary biology, structural virology, and therapeutic innovation. As phage therapy continues to gain momentum, these insights will be critical to harnessing the full potential of bacteriophages in combating bacterial diseases.

Subject of Research:
The molecular mechanisms by which Gp38 adhesins of Straboviridae bacteriophages recognize and bind specific extracellular loops on bacterial outer membrane protein receptors.

Article Title:
Gp38 adhesins of Straboviridae phages recognize specific extracellular loops of outer membrane protein receptors.

Article References:
Lutz, V.T., Klein-Sousa, V., Bojer, M.S. et al. Gp38 adhesins of Straboviridae phages recognize specific extracellular loops of outer membrane protein receptors. npj Viruses 3, 37 (2025). https://doi.org/10.1038/s44298-025-00118-9

Image Credits:
AI Generated